IXHL

Incannex Healthcare Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 0/10
Incannex Healthcare sales and earnings growth
IXHL Growth
Good
  • Revenue Y/Y↓ -100.00%
  • EPS Y/Y↑ 46.04%
  • FCF Y/Y↓ -16.14%
Incannex Healthcare gross and profit margin trends
IXHL Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 0.00%
Incannex Healthcare net debt vs free cash flow
IXHL Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -366.4

Incannex Healthcare stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗